Marcello Capra

1.8k total citations
32 papers, 1.1k citations indexed

About

Marcello Capra is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Marcello Capra has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Genetics, 16 papers in Hematology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Marcello Capra's work include Hemoglobinopathies and Related Disorders (28 papers), Iron Metabolism and Disorders (16 papers) and Hepatitis B Virus Studies (5 papers). Marcello Capra is often cited by papers focused on Hemoglobinopathies and Related Disorders (28 papers), Iron Metabolism and Disorders (16 papers) and Hepatitis B Virus Studies (5 papers). Marcello Capra collaborates with scholars based in Italy, United States and Argentina. Marcello Capra's co-authors include Aurelio Maggio, Massimo Midiri, Vincenzo Positano, Alessia Pepe, Roberto Malizia, Luciano Prossomariti, Eliana Cracolici, Antonio Craxı̀, C Ciaccio and V. Di Marco and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Energy Conversion and Management.

In The Last Decade

Marcello Capra

31 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcello Capra Italy 18 789 696 200 161 151 32 1.1k
Liana Cuccia Italy 17 625 0.8× 528 0.8× 67 0.3× 31 0.2× 105 0.7× 45 810
Lorella Pitrolo Italy 11 453 0.6× 391 0.6× 61 0.3× 45 0.3× 84 0.6× 27 628
Patricia Griffith United States 12 952 1.2× 1.1k 1.6× 74 0.4× 17 0.1× 204 1.4× 14 1.4k
M. Messner France 17 191 0.2× 274 0.4× 544 2.7× 569 3.5× 22 0.1× 34 1.1k
Jhon Prieto United States 10 115 0.1× 181 0.3× 159 0.8× 140 0.9× 28 0.2× 22 510
Kaan Kavaklı Türkiye 19 269 0.3× 755 1.1× 75 0.4× 6 0.0× 70 0.5× 81 1.2k
J.J. Veltkamp Netherlands 16 161 0.2× 477 0.7× 28 0.1× 23 0.1× 28 0.2× 39 788
Angelika Bátorová Slovakia 22 316 0.4× 1.5k 2.2× 25 0.1× 15 0.1× 50 0.3× 77 1.7k
Edith Bigot‐Corbel France 15 106 0.1× 132 0.2× 92 0.5× 19 0.1× 23 0.2× 54 575
F Duckert Switzerland 13 112 0.1× 373 0.5× 69 0.3× 22 0.1× 14 0.1× 45 760

Countries citing papers authored by Marcello Capra

Since Specialization
Citations

This map shows the geographic impact of Marcello Capra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcello Capra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcello Capra more than expected).

Fields of papers citing papers by Marcello Capra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcello Capra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcello Capra. The network helps show where Marcello Capra may publish in the future.

Co-authorship network of co-authors of Marcello Capra

This figure shows the co-authorship network connecting the top 25 collaborators of Marcello Capra. A scholar is included among the top collaborators of Marcello Capra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcello Capra. Marcello Capra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marocco, Paolo, et al.. (2024). Design of hydrogen production systems powered by solar and wind energy: An insight into the optimal size ratios. Energy Conversion and Management. 314. 118646–118646. 27 indexed citations
2.
Pepe, Alessia, Antonella Meloni, Zelia Borsellino, et al.. (2015). Myocardial fibrosis by late gadolinium enhancement cardiac magnetic resonance and hepatitis C virus infection in thalassemia major patients. Journal of Cardiovascular Medicine. 16(10). 689–689. 26 indexed citations
3.
Filosa, Aldo, Angela Vitrano, Paolo Rigano, et al.. (2013). Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major. Blood Cells Molecules and Diseases. 51(2). 85–88. 26 indexed citations
4.
Maggio, Aurelio, Angela Vitrano, Marcello Capra, et al.. (2012). Long‐term use of deferiprone significantly enhances left‐ventricular ejection function in thalassemia major patients. American Journal of Hematology. 87(7). 732–733. 30 indexed citations
5.
Marco, V. Di, F. Bronte, Vincenza Calvaruso, et al.. (2011). IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection. Haematologica. 97(5). 679–686. 46 indexed citations
6.
Vitrano, Angela, Liana Cuccia, Aurelio Maggio, et al.. (2010). Reliability of EMA Binding Test in the Diagnosis of Hereditary Spherocytosis in Italian Patients. Acta Haematologica. 125(3). 136–140. 11 indexed citations
7.
Meloni, Antonella, Marcello Capra, P Cianciulli, et al.. (2010). Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging. Haematologica. 96(1). 41–47. 119 indexed citations
8.
Marco, V. Di, F. Bronte, Daniela Cabibi, et al.. (2009). Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) – lack of interference by iron deposition. British Journal of Haematology. 148(3). 476–479. 42 indexed citations
9.
Meloni, Antonella, Alessia Pepe, Vincenzo Positano, et al.. (2009). Influence of myocardial fibrosis and blood oxygenation on heart T2* values in thalassemia patients. Journal of Magnetic Resonance Imaging. 29(4). 832–837. 26 indexed citations
10.
Cappellini, Maria Domenica, Silverio Perrotta, Leyla Ağaoğlu, et al.. (2009). Efficacy and Safety of Deferasirox (Exjade®) in Patients with β-Thalassemia Major Treated for up to 5 Years.. Blood. 114(22). 4063–4063. 4 indexed citations
11.
Pepe, Alessia, Vincenzo Positano, Marcello Capra, et al.. (2009). Myocardial scarring by delayed enhancement cardiovascular magnetic resonance in thalassaemia major. Heart. 95(20). 1688–1693. 75 indexed citations
12.
Cuccia, Liana, et al.. (2008). Hb Hinwil [β38(C4)Thr→Asn, A C C>A A C] Associated with β 0 -Thalassemia in a Sicilian Child. Hemoglobin. 32(6). 582–587. 2 indexed citations
13.
Marco, V. Di, Marcello Capra, Francesco Gagliardotto, et al.. (2008). Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C. Haematologica. 93(8). 1243–1246. 38 indexed citations
14.
Pepe, Alessia, Massimo Lombardi, Vincenzo Positano, et al.. (2006). Evaluation of the efficacy of oral deferiprone in β‐thalassemia major by multislice multiecho T2*. European Journal Of Haematology. 76(3). 183–192. 107 indexed citations
15.
Filosa, Aldo, Luca Valgimigli, Gian Franco Pedulli, et al.. (2005). Quantitative evaluation of oxidative stress status on peripheral blood in β‐thalassaemic patients by means of electron paramagnetic resonance spectroscopy. British Journal of Haematology. 131(1). 135–140. 10 indexed citations
16.
17.
Angioletti, Maria De, et al.. (2002). Hb A2-MONREALE [δ146(HC3)His → Arg], A NOVEL δ CHAIN VARIANT DETECTED IN WEST SICILY. Hemoglobin. 26(1). 1–5. 2 indexed citations
18.
Maggio, Aurelio, Gennaro D’Amico, Alberto Morabito, et al.. (2002). Deferiprone versus Deferoxamine in Patients with Thalassemia Major: A Randomized Clinical Trial. Blood Cells Molecules and Diseases. 28(2). 196–208. 154 indexed citations
19.
20.
Marco, V. Di, Oreste Lo Iacono, Piero Luigi Almasio, et al.. (1997). Long-Term Efficacy of α-Interferon in β-Thalassemics With Chronic Hepatitis C. Blood. 90(6). 2207–2212. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liana Cuccia Breakdown of academic impact, for papers by Lorella Pitrolo Breakdown of academic impact, for papers by Patricia Griffith Breakdown of academic impact, for papers by M. Messner Breakdown of academic impact, for papers by Jhon Prieto Breakdown of academic impact, for papers by Kaan Kavaklı Breakdown of academic impact, for papers by J.J. Veltkamp Breakdown of academic impact, for papers by Angelika Bátorová Breakdown of academic impact, for papers by Edith Bigot‐Corbel Breakdown of academic impact, for papers by F Duckert
Rankless by CCL
2026